Siel Bleu and Boehringer Ingelheim

A. Next Steps - based on Impact of pilot projects:

• Expand to other jurisdictions in Spain
• Leverage Siel Bleu’s presence in other countries ( France, Belgium and Ireland)

B. Enhancements/evolutions to consider
• Pilot was limited to IPF patients – now they can extend to a wider group of
aging populations – include those suffering from other chronic illnesses
• Include healthy seniors and sell services as a preventive measure – to keep
away from chronic illnesses
Siel Bleu and Boehringer Ingelheim
C. Other partner or stakeholder to consider
• Local government bodies – healthcare/ social development
• The services provided by SB+BI are contributing to the wellness of seniors in
local areas. This will reduce the costs of government in healthcare budgets on
prescription drugs, doctor visits, ER visits.
• They can subsidize the costs of the services by offering to co-pay part of the
fees charged to individuals, and part can be covered by insurance.
• It’s a win-win for all parties concerned – patients and service providers and
community in general.